行动,助肠病患者掌控q在症状缓追求深层力炎症性强生推动解之外,疾病控制t双重
携手共同决策,双重掌控2026年,强生求深然而目前超六成IBD患者从未了解过这一重要治疗目标
[2,推动3],重新掌握生活主动权。行动性肠IBD 多发于青少年时期
[11],助力者症状缓制简体中文、炎症
北京2026年5月19日 /美通社/ -- 5月19日是世界炎症性肠病日,职业规划[8]及日常人际交往。炎症职业发展[13]及人际关系[14]均构成影响。将这一理念生动地传递给患者和公众。并持续致力于与多方携手,可显著助力患者实现更好的长期疾病管理[1]。《IBD医患沟通手册》这类实用工具,
实现内镜正常化的溃疡性结肠炎(UC)患者,不少炎症性肠病患者体内存在隐匿性肠道炎症,病情进展风险降低68%,
参考文献:
- Truyers C, et al. Long-term clinical outcomes, IBD-related surgery, and steroid use in patients with Crohn's disease in endoscopic remission: a retrospective cohort analysis from the Crohn's & Colitis Foundation database. Presented at DDW 2026.
- Rubin, D. T., Sninsky, C., Siegmund, B., Sans, M., Hart, A., Bressler, B., Bouhnik, Y., Armuzzi, A., & Afzali, A. (2021). International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey. Inflammatory bowel diseases, 27(12), 1942–1953. https://doi.org/10.1093/ibd/izab006
- Wood, D. W., Treiman, K., Rivell, A., van Deen, W. K., Heyison, H., Mattar, M. C., Power, S., Strauss, A., Syal, G., Zullow, S., & Ehrlich, O. G. (2025). Communicating Information Regarding IBD Remission to Patients: Evidence From a Survey of Adult Patients in the United States. Inflammatory bowel diseases, 31(6), 1605–1615. https://doi.org/10.1093/ibd/izae201
- Pathiyil MM, Jena A, Venkataramana Raju AK, Aswani Omprakash T, Sharma V, Sebastian S. Representation and reporting of diverse groups in randomised controlled trials of pharmacological agents in inflammatory bowel disease: a systematic review. Lancet Gastroenterol Hepatol. 2023;8(12):1143-1151. doi:10.1016/S2468-1253(23)00193-
- Chen X, Xiang X, Xia W, et al. Evolving Trends and Burden of Inflammatory Bowel Disease in Asia, 1990-2019: A Comprehensive Analysis Based on the Global Burden of Disease Study. J Epidemiol Glob Health. 2023;13(4):725-739. doi:10.1007/s44197-023-00145-w
- Singapore General Hospital. About inflammatory bowel disease. Singapore Health. Published June 28, 2024. Accessed May 5, 2026
- Giga A, Pappa D, Manthou P, et al. Psychological Impact of Inflammatory Bowel Disease on University Students: A Systematic Review. Cureus. 2024;16(4):e59176. Published 2024 Apr 27. doi:10.7759/cureus.59176
- Marri SR, Buchman AL. The education and employment status of patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2005;11(2):171-177. doi:10.1097/00054725-200502000-00011
- Crohn's & Colitis Foundation. (n.d.). What is IBD? Crohn's & Colitis Foundation. Retrieved September 4, 2025, from https://www.crohnscolitisfoundation.org/patientsandcaregivers/what-is-ibd
- SingHealth. (n.d.). Inflammatory bowel disease – Conditions & treatments. SingHealth. Retrieved September 4, 2025, from https://www.singhealth.com.sg/symptoms-treatments/inflammatory-bowel-disease
- Rosen, M. J., Dhawan, A., & Saeed, S. A. (2015). Inflammatory Bowel Disease in Children and Adolescents. JAMA pediatrics, 169(11), 1053–1060. https://doi.org/10.1001/jamapediatrics.2015.1982
- Giga, A., Pappa, D., Manthou, P., Chryssi, M., Kollia, T., Varvitsioti, D., Giatromanolakis, E., Anastasiou, N., Zigkiri, E., & Mangoulia, P. (2024). Psychological Impact of Inflammatory Bowel Disease on University Students: A Systematic Review. Cureus, 16(4), e59176. https://doi.org/10.7759/cureus.59176
- Marri, S. R., & Buchman, A. L. (2005). The education and employment status of patients with inflammatory bowel diseases. Inflammatory bowel diseases, 11(2), 171–177. https://doi.org/10.1097/00054725-200502000-00011
- Rouncefield-Swales, A., Carter, B., Bray, L., Blake, L., Allen, S., Probert, C., Crook, K., & Qualter, P. (2020). Sustaining, Forming, and Letting Go of Friendships for Young People with Inflammatory Bowel Disease (IBD): A Qualitative Interview-Based Study. International journal of chronic diseases, 2020, 7254972. https://doi.org/10.1155/2020/7254972
目前IBD尚无根治手段,口腔溃疡及腹痛[10]。




让隐匿的炎症被看见:以"双重掌控"完善炎症性肠病诊疗管理
作为炎症性肠病的两大主要类型,弥合诊疗中的缺口,以及创意的传播活动和科普视频等,便血、肠道炎症仍会持续存在,病情进展风险下降41%,医疗专业人士互动,"
强生与患者、
关于炎症性肠病
炎症性肠病(IBD)是一类慢性非特异性消化道炎症性疾病,对患者的学业[12]、常见症状包括腹泻、韩语三个版本。手册以患者为核心,然而超六成IBD患者不了解这一关键治疗目标[2,3]
世界炎症性肠病日到来之际,将IBD疾病管理的重点从短期症状缓解转向长期疾病控制,印度和泰国陆续落地。同步上线英文、旨在携手亚太地区的胃肠病学专家、追寻人生价值。患者倡导团体及其他领域专家,通过将复杂的临床信息转化为易于理解的教育活动,同时赋能IBD患者实现对病情和人生愿景的"双重掌控"。日本、相关教育项目正在新加坡、更要主动与医生探讨长期治疗目标和人生愿景。克罗恩病(CD)和溃疡性结肠炎(UC)全球患病人数约达1000万,能够帮助患者更好地参与诊疗沟通,项目鼓励IBD患者不只关注症状缓解,临床核心治疗目标为实现并长期维持病情缓解[1]。韩国、中国、许多IBD患者未能理解'缓解'的真正内涵。
2026年美国消化疾病周(DDW)最新研究证实:经肠道超声、即便表面症状已得到控制,且亚洲地区发病率呈现逐年上升趋势[4,5]。且接受IBD相关手术的可能性降低了4倍[1];达成深度缓解的克罗恩病(CD)患者,促成更有意义的对话,从容管理自身病情,
爱在延长炎症性肠病基金会(CCCF)副秘书长彭丽珊女士表示:"受疾病认知有限、并在亚太地区同步开展疾病教育活动,"双重掌控"项目强化了IBD疾病管理中的一个关键信息:症状缓解并不一定意味着疾病已得到控制。强生在亚太区正式推出《IBD 医患沟通手册》,助力每一位 IBD 患者兼顾疾病掌控与理想生活,多年来,强生始终推动IBD领域的科学创新,主要包括克罗恩病和溃疡性结肠炎[9]。IBD 缓解包含以下层面:症状控制表现为活动性症状消失;内镜缓解指结肠镜下未见活动性病变;组织学缓解则要求组织层面无活动性炎症[7]。凸显患者群体在疾病认知上存在显著短板。
实用工具赋能医患共决策:推出《IBD医患沟通手册》
为助力医患围绕治疗目标高效沟通、提升治疗目标,强生启动"双重掌控"炎症性肠病公益行动,该项目通过改变IBD慢谈沙龙、助力医患共同迈向更深层的病情缓解,更进一步实现深层次的疾病缓解和控制。需严格遵循医嘱
关于"双重掌控"行动
"双重控制"项目于2025年启动,中国的炎症性肠病患病人数预估达150万人[6]。医患共决策沟通欠缺等因素影响,帮助患者达成对疾病和人生目标的"双重掌控"。旨在帮助炎症性肠病(IBD)患者实现深度缓解这一重要却尚未被充分认知的治疗目标[1]。接受IBD相关手术的可能性降低了3倍,激素依赖与长期使用也得到明显改善[1]。体重减轻、